Synopsis of recent research by authors named "C Denkert"
- C Denkert's research primarily focuses on the evaluation of treatment strategies and prognostic markers in various types of cancer, particularly breast and colorectal cancers, through large cohort studies and randomized trials.
- Recent studies by Denkert include assessing on-treatment biopsies to predict responses to neoadjuvant chemotherapy in invasive breast cancer and analyzing the overall survival benefits of pembrolizumab for early-stage triple-negative breast cancer.
- Additionally, Denkert's investigations extend to the role of TROP2 in colorectal carcinoma and the effects of BAG6 on pancreatic cancer progression, highlighting significant correlations between biomarker expression, histopathological characteristics, and patient outcomes.
